Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
03 Jul 2023
Historique:
received: 18 05 2023
accepted: 13 06 2023
medline: 5 7 2023
pubmed: 4 7 2023
entrez: 3 7 2023
Statut: epublish

Résumé

Psychotic disorders often develop a chronic course with devastating consequences for individuals, families, and societies. Early intervention programs for people in the first 5 years after the initial psychotic episode (early psychosis) can significantly improve the outcome and are therefore strongly recommended in national and international guidelines. However, most early intervention programs still focus on improving symptoms and relapse prevention, rather than targeting educational and vocational recovery. The aim of the present study is to explore the effects of Supported Employment and Education (SEE) following the Individual Placement and Support (IPS) model in people with early psychosis. The SEEearly trial compares treatment as usual (TAU) plus SEE to TAU alone in outpatient psychiatric settings. The study is a six-site, two-arm, single-blinded, superiority randomized controlled trial (RCT). Participants are randomly assigned (1:1) to the intervention or control group. Aiming to recruit 184 participants, with an assumed drop-out rate of 22%, we will be able to detect a 24% difference in the main outcome of employment/education with 90% power. We make assessments at baseline and at 6- and 12-month follow-ups. Outcome data on employment/education, medication, and current psychiatric treatment is obtained monthly through phone based short assessments. The primary outcome is steady participation for at least 50% of the 12-month follow-up in competitive employment and/or mainstream education. Secondary employment outcomes capture length of employment/education, time to first employment/education, monthly wages/educational attainment, and social return on investment (SROI). Secondary non-employment outcomes include subjective quality of life, psychopathology, substance use, relapse, hospitalization, and functional impairment. To be eligible, participants must be between 16 and 35 years, fulfill diagnostic criteria for early psychosis, and be interested in competitive employment and/or mainstream education. In SEEearly, we hypothesize that participants with psychosis, who receive TAU plus SEE, present with better primary and secondary outcomes than participants, who receive TAU alone. Positive results of this study will justify SEE as an evidence-based strategy for clinical routine treatment in people with early psychosis. SEEearly was registered nationally and internationally in the German Clinical Trials Register (DRKS; identifier: DRKS00029660) on October 14, 2022.

Sections du résumé

BACKGROUND BACKGROUND
Psychotic disorders often develop a chronic course with devastating consequences for individuals, families, and societies. Early intervention programs for people in the first 5 years after the initial psychotic episode (early psychosis) can significantly improve the outcome and are therefore strongly recommended in national and international guidelines. However, most early intervention programs still focus on improving symptoms and relapse prevention, rather than targeting educational and vocational recovery. The aim of the present study is to explore the effects of Supported Employment and Education (SEE) following the Individual Placement and Support (IPS) model in people with early psychosis.
METHODS METHODS
The SEEearly trial compares treatment as usual (TAU) plus SEE to TAU alone in outpatient psychiatric settings. The study is a six-site, two-arm, single-blinded, superiority randomized controlled trial (RCT). Participants are randomly assigned (1:1) to the intervention or control group. Aiming to recruit 184 participants, with an assumed drop-out rate of 22%, we will be able to detect a 24% difference in the main outcome of employment/education with 90% power. We make assessments at baseline and at 6- and 12-month follow-ups. Outcome data on employment/education, medication, and current psychiatric treatment is obtained monthly through phone based short assessments. The primary outcome is steady participation for at least 50% of the 12-month follow-up in competitive employment and/or mainstream education. Secondary employment outcomes capture length of employment/education, time to first employment/education, monthly wages/educational attainment, and social return on investment (SROI). Secondary non-employment outcomes include subjective quality of life, psychopathology, substance use, relapse, hospitalization, and functional impairment. To be eligible, participants must be between 16 and 35 years, fulfill diagnostic criteria for early psychosis, and be interested in competitive employment and/or mainstream education.
DISCUSSION CONCLUSIONS
In SEEearly, we hypothesize that participants with psychosis, who receive TAU plus SEE, present with better primary and secondary outcomes than participants, who receive TAU alone. Positive results of this study will justify SEE as an evidence-based strategy for clinical routine treatment in people with early psychosis.
TRIAL REGISTRATION BACKGROUND
SEEearly was registered nationally and internationally in the German Clinical Trials Register (DRKS; identifier: DRKS00029660) on October 14, 2022.

Identifiants

pubmed: 37400899
doi: 10.1186/s13063-023-07462-2
pii: 10.1186/s13063-023-07462-2
pmc: PMC10316586
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

440

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 470569697

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016;15(7):485–515.
pubmed: 26939910 doi: 10.1038/nrd.2016.28
Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3–10.
pubmed: 23800613 doi: 10.1016/j.schres.2013.05.028
Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296–306.
pubmed: 23172003 doi: 10.1093/schbul/sbs130
Gore FM, Bloem PJN, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10–24 years: a systematic analysis. Lancet. 2011;377(9783):2093–102.
pubmed: 21652063 doi: 10.1016/S0140-6736(11)60512-6
König HH, Friemel S. Gesundheitsökonomie psychischer Krankheiten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006;49:46–56.
pubmed: 16362133 doi: 10.1007/s00103-005-1195-2
Kane J, Schooler N, Marcy P, Correll C, Brunette M, Mueser K, et al. The RAISE early treatment program for first-episode psychosis. J Clin Psychiatry. 2015;76(3):240–6.
pubmed: 25830446 pmcid: 7477907 doi: 10.4088/JCP.14m09289
Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, Kuipers E. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry. 2010;197(5):350–6.
pubmed: 21037211 pmcid: 2966501 doi: 10.1192/bjp.bp.109.074526
Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. Effectiveness of early intervention services for early-phase psychosis. JAMA Psychiatry. 2018;75(6):555–65.
pubmed: 29800949 pmcid: 6137532 doi: 10.1001/jamapsychiatry.2018.0623
Maraj A, Mustafa S, Joober R, Malla A, Shah JL, Iyer SN. Caught in the “NEET trap”: the intersection between vocational inactivity and disengagement from an early intervention service for psychosis. Psychiatr Serv. 2019;70(4):302–8.
pubmed: 30717644 doi: 10.1176/appi.ps.201800319
DGPPN, editor. S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen. 2nd ed. Berlin, Heidelberg: Springer; 2019.
DGPPN, editor. S3-Behandlungsleitlinie Schizophrenie. Berlin, Heidelberg: Springer; 2019.
NICE. Psychosis and schizophrenia in adults: prevention and management. NICE guidelines [CG178]. 2014. Available from: https://www.nice.org.uk/guidance/cg178 .
Mueser KT, Deavers F, Penn DL, Cassisi JE. Psychosocial treatments for schizophrenia. Annu Rev Clin Psychol. 2013;9:465–97.
pubmed: 23330939 doi: 10.1146/annurev-clinpsy-050212-185620
de Waal A, Dixon LB, Humensky JL. Association of participant preferences on work and school participation after a first episode of psychosis. Early Interv Psychiatry. 2018;12(5):959–63.
pubmed: 29052948 doi: 10.1111/eip.12513
Killackey E. Resignation not accepted: employment, education and training in early intervention, past, present and future. Early Interv Psychiatry. 2015;9(6):429–32.
pubmed: 26487488 doi: 10.1111/eip.12292
Bond GR, Drake RE, Campbell K. Effectiveness of individual placement and support supported employment for young adults. Early Interv Psychiatry. 2016;10(4):300–7.
pubmed: 25138195 doi: 10.1111/eip.12175
Drake RE, Bond GR, Becker DR. Individual placement and support: an evidence-based approach to supported employment. New York: Oxford University Press; 2012.
doi: 10.1093/acprof:oso/9780199734016.001.0001
Swanson SJ, Becker DR, Bond GR, Ellison ML. IPS supported employment for youth: helping transition age youth with serious mental health conditions to access education, jobs, and careers. Worcester: University of Massachusetts Medical School, Department of Psychiatry, Transitions to Adulthood Center for Research; 2020.
Frederick DE, VanderWeele TJ. Supported employment: meta-analysis and review of randomized controlled trials of individual placement and support. PLoS One. 2019;14(2):e0212208.
pubmed: 30785954 pmcid: 6382127 doi: 10.1371/journal.pone.0212208
Killackey E, Allott K, Jackson HJ, Scutella R, Tseng YP, Borland J, et al. Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial. Br J Psychiatry. 2019;214(2):76–82.
pubmed: 30251616 doi: 10.1192/bjp.2018.191
Nuechterlein KH, Subotnik KL, Ventura J, Turner LR, Gitlin MJ, Gretchen-Doorly D, et al. Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training. Psychol Med. 2020;50(1):20–8.
pubmed: 30606273 doi: 10.1017/S0033291718003860
Hoffmann H, Jäckel D, Glauser S, Mueser KT, Kupper Z. Long-term effectiveness of supported employment: five-year follow-up of a randomized controlled trial. Am J Psychiatry. 2014;171(11):1183–90.
pubmed: 25124692 doi: 10.1176/appi.ajp.2014.13070857
Jäckel D, Kupper Z, Glauser S, Mueser KT, Hoffmann H. Effects of sustained competitive employment on psychiatric hospitalizations and quality of life. Psychiatr Serv. 2017;68(6):603–9.
pubmed: 28142387 doi: 10.1176/appi.ps.201600083
Luciano A, Bond GR, Drake RE. Does employment alter the course and outcome of schizophrenia and other severe mental illnesses? A systematic review of longitudinal research. Schizophr Res. 2014;159(2–3):312–21.
pubmed: 25278105 doi: 10.1016/j.schres.2014.09.010
OECD. Education at a glance 2020: OECD indicators. 2020.
Erickson DH, Roes MM, DiGiacomo A, Burns A. “Individual placement and support” boosts employment for early psychosis clients, even when baseline rates are high. Early Interv Psychiatry. 2020. https://doi.org/10.1111/eip.13005 .
Rosenheck R, Mueser KT, Sint K, Lin H, Lynde DW, Glynn SM, et al. Supported employment and education in comprehensive, integrated care for first episode psychosis: effects on work, school, and disability income. Schizophr Res. 2017;128:120–8.
doi: 10.1016/j.schres.2016.09.024
Sveinsdottir V, Lie SA, Bond GR, Eriksen HR, Tveito TH, Grasdal AL, et al. Individual placement and support for young adults at risk of early work disability (the SEED trial). A randomized controlled trial. Scand J Work Environ Health. 2019;45(1):33–41.
pubmed: 30074050
Bond GR, Drake R, Luciano A. Employment and educational outcomes in early intervention programmes for early psychosis: a systematic review. Epidemiol Psychiatr Sci. 2015;24(5):446–57.
pubmed: 25016950 doi: 10.1017/S2045796014000419
IPS Employment Center. IPS fidelity scale for young adults. IPS Employment Center; 2019. Available from: https://ipsworks.org/wp-content/uploads/2019/03/IPS-fidelity-scale-for-young-adults-3-27-19.pdf .
Becker DR, Swanson S, Bond GR, Merrens MR. Evidence-based Supported Employment fidelity review manual. 2nd edn. 2011. Available from: http://sites.dartmouth.edu/ips/fidelity/fidelity-review-manual/ .
Bond GR, Kukla M. Is job tenure brief in Individual Placement and Support (IPS) employment programs? Psychiatr Serv. 2011;62(8):950–3.
pubmed: 21807836 doi: 10.1176/ps.62.8.pss6208_0950
Davis LL, Blansett CM, Mumba MN, MacVicar D, Toscano R, Pilkinton P, et al. The methods and baseline characteristics of a VA randomized controlled study evaluating supported employment provided in primary care patient aligned care teams. BMC Med Res Methodol. 2020;20(1):33.
pubmed: 32066380 pmcid: 7027030 doi: 10.1186/s12874-020-0919-1
Rogers ES, Kash-MacDonald M, Bruker D, Maru M. Systematic review of supported education literature 1989–2009. Boston: Boston University, Sargent College, Center for Psychiatric Rehabilitation; 2010. http://www.bu.edu/drrk/research-syntheses/psychiatric-disabilities/supported-education/ .
Bond GR, Campbell K, Drake RE. Standardizing measures in four domains of employment outcomes for Individual Placement and Support. Psychiatr Serv. 2012;63(8):751–7.
pubmed: 22660524 doi: 10.1176/appi.ps.201100270
HegelstadWenche ten V, Joa I, Heitmann L, Johannessen Jan O, Langeveld J. Job- and schoolprescription: a local adaptation to individual placement and support for first episode psychosis. Early Interv Psychiatry. 2019;13(4):859–66.
doi: 10.1111/eip.12686
Killackey E, Allott K, Cotton SM, Jackson H, Scutella R, Tseng Y-P, et al. A randomized controlled trial of vocational intervention for young people with first-episode psychosis: method. Early Interv Psychiatry. 2013;7(3):329–37.
pubmed: 23848427 doi: 10.1111/eip.12066
Davis LL, Kyriakides TC, Suris AM, Ottomanelli LA, Mueller L, Parker PE, et al. Effect of evidence-based Supported Employment vs transitional work on achieving steady work among veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2018;75(4):316–24.
pubmed: 29490371 pmcid: 5875356 doi: 10.1001/jamapsychiatry.2017.4472
Killackey E, Allott K, Woodhead G, Connor S, Dragon S, Ring J. Individual placement and support, supported education in young people with mental illness: an exploratory feasibility study. Early Interv Psychiatry. 2017:Advance online publication. 28.04.2016. https://doi.org/10.1111/eip.12344 .
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
pubmed: 3616518 doi: 10.1093/schbul/13.2.261
Opler MGA, Yavorsky C, Daniel DG. Positive and Negative Syndrome Scale (PANSS) Training: challenges, solutions, and future directions. Innov Clin Neurosci. 2017;14(11–12):77–81.
pubmed: 29410941 pmcid: 5788255
Linden M, Baron S, Muschalla B. Relationship between work-related attitudes, performance and capacities according to the ICF in patients with mental disorders. Psychopathology. 2010;43(4):262–7.
pubmed: 20516752 doi: 10.1159/000315125
Rössler W, Ujeyl M, Kawohl W, Nordt C, Lasalvia A, Haker H, et al. Predictors of employment for people with mental illness: results of a multicenter randomized trial on the effectiveness of placement budgets for Supported Employment. Front Psychiatry. 2019;10:518.
pubmed: 31379630 pmcid: 6659611 doi: 10.3389/fpsyt.2019.00518
Aas IHM. Global Assessment of Functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry. 2010;9:20.
pubmed: 20459646 pmcid: 2880316 doi: 10.1186/1744-859X-9-20
McLellan AT, Carise D, Coyne TH. Addiction Severity Index 5th Edition. J Subst Abuse Treat. 1992;9:199–213.
pubmed: 1334156 doi: 10.1016/0740-5472(92)90062-S
Leonhard C, Mulvey K, Gastfriend DR, Shwartz M. The Addiction Severity Index: a field study of internal consistency and validity. J Subst Abuse Treat. 2000;18(2):129–35.
pubmed: 10716096 doi: 10.1016/S0740-5472(99)00025-2
Rosen CS, Henson BR, Finney JW, Moos RH. Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction. 2000;95(3):419–25.
pubmed: 10795362 doi: 10.1046/j.1360-0443.2000.95341912.x
Cuttler C, Spradlin A. Measuring cannabis consumption: psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU). PLoS One. 2017;12(5):e0178194.
pubmed: 28552942 pmcid: 5446174 doi: 10.1371/journal.pone.0178194
Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF. Handbuch für die deutsche Version der WHO Instrumente zur Erfassung von Lebensqualität. Göttingen: Hogrefe; 2000.
Millar R, Hall K. Social Return on Investment (SROI) and Performance Measurement: the opportunities and barriers for social enterprises in health and social care. Public Manag Rev. 2013;15(6):923–41.
doi: 10.1080/14719037.2012.698857
Phillips JJ. Return on investment in training and performance improvement programs. 2nd ed. Burlington: Elsevier; 2003.
Luppa M, Luck T, Heinrich S, Glaesmer H. Forschung zur Versorgung von Patienten mit psychischen Störungen. Z Psychiatr Psychol Psychother. 2008;56(3):203–10.
Jackson B, Dimmock JA, Taylor IM, Hagger MS. The tripartite efficacy framework in client-therapist rehabilitation interactions: implications for relationship quality and client engagement. Rehabil Psychol. 2012;57(4):308–19.
pubmed: 23148714 doi: 10.1037/a0030062
Chan F, McMahon BT, Shaw LR, Lee G. Psychometric validation of the expectations about rehabilitation counseling scale: a preliminary study. J Vocat Rehabil. 2004;20:127–33.
Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;36(2):223–33.
doi: 10.1037/0022-0167.36.2.223
van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67.
Demke E, Mahlke C, Bock T. EmPeeRie-Empower Peers to Research-Vorstellung eines Hamburger Projekts zur Förderung von Partizipativer und betroffenenkontrollierter Forschung. Sozialpsychiatrische Informationen. 2017;47(2):43–6.
Killackey E, Jackson HJ, McGorry PD. Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. Br J Psychiatry. 2008;193(2):114–20.
pubmed: 18669993 doi: 10.1192/bjp.bp.107.043109
Humensky JL, Turner LR, Dixon LB, Drake RE, Becker DR, Subotnik KL, et al. Personnel time required for supported employment and education services for individuals in a recent-onset psychosis treatment program. Early Interv Psychiatry. 2020;15:402–5.
pubmed: 32351048 pmcid: 7606755 doi: 10.1111/eip.12971

Auteurs

D Jäckel (D)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.

A Willert (A)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany. anna.willert@charite.de.
Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany. anna.willert@charite.de.

A Brose (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.

K Leopold (K)

Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.
Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.

D Nischk (D)

Department of Social Psychiatry, Zentrum für Psychiatrie, Reichenau, Germany.

S Senner (S)

Department of Social Psychiatry, Zentrum für Psychiatrie, Reichenau, Germany.

O Pogarell (O)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

S Sachenbacher (S)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

M Lambert (M)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

A Rohenkohl (A)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

P Kling-Lourenco (P)

Department of Psychiatry II, University of Ulm and BKH Günzburg, Ulm, Germany.

N Rüsch (N)

Department of Psychiatry II, University of Ulm and BKH Günzburg, Ulm, Germany.

F Bermpohl (F)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
Psychiatric University Clinic of Charité at St. Hedwig Hospital, Berlin, Germany.

M Schouler-Ocak (M)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
Psychiatric University Clinic of Charité at St. Hedwig Hospital, Berlin, Germany.

V Disselhoff (V)

Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.

U Skorupa (U)

Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.

A Bechdolf (A)

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany.
Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH